Hepatic Arterial Infusion Chemotherapy for Advanced Hepatocellular Carcinoma in Japan
Transcatheter methods such as transcatheter arterial chemoembolization (TACE) and hepatic arterial infusion chemotherapy (HAIC) have an important role in the treatment for advanced hepatocellular carcinoma (HCC). Recently, sorafenib, an inhibitor of tyrosine kinases, has been found to obtain surviva...
Main Authors: | Ryuichi Kita, Toru Kimura, Hiroki Nishikawa, Yukio Osaki |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2012-02-01
|
Series: | Cancers |
Subjects: | |
Online Access: | http://www.mdpi.com/2072-6694/4/1/165/ |
Similar Items
-
Clinical Benefits of Hepatic Arterial Infusion Chemotherapy for Advanced Hepatocellular Carcinoma
by: Takahiro Yamasaki, et al.
Published: (2021-02-01) -
Hepatic Arterial Infusion Chemotherapy versus Sorafenib in Patients with Advanced Hepatocellular Carcinoma
by: Kazuomi Ueshima, et al.
Published: (2020-07-01) -
Efficacy of sequential sorafenib plus hepatic arterial infusion chemotherapy in patients with Barcelona Clinic Liver Cancer stage B and C hepatocellular carcinoma: a retrospective single-institution study
by: Shinichi Ikuta, et al.
Published: (2018-09-01) -
Hepatic Arterial Infusion Chemotherapy of Oxaliplatin, Fluorouracil, and Leucovorin With or Without Sorafenib as Initial Treatment for Advanced Hepatocellular Carcinoma
by: Run-Bin Liang, et al.
Published: (2021-05-01) -
Transcatheter hepatic arterial infusion chemotherapy vs sorafenib in the treatment of patients with hepatocellular carcinoma of Barcelona Clinic Liver Cancer stage C: a meta-analysis of Asian population
by: Ni JY, et al.
Published: (2018-11-01)